nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—GABRG2—epilepsy syndrome	0.105	0.312	CbGaD
Zaleplon—GABRB3—epilepsy syndrome	0.0845	0.252	CbGaD
Zaleplon—GABRB2—epilepsy syndrome	0.0739	0.22	CbGaD
Zaleplon—GABRA1—epilepsy syndrome	0.0725	0.216	CbGaD
Zaleplon—TSPO—Clonazepam—epilepsy syndrome	0.037	0.0854	CbGbCtD
Zaleplon—TSPO—Diazepam—epilepsy syndrome	0.0223	0.0514	CbGbCtD
Zaleplon—AOX1—Zonisamide—epilepsy syndrome	0.0182	0.042	CbGbCtD
Zaleplon—GABRB2—Clonazepam—epilepsy syndrome	0.0141	0.0326	CbGbCtD
Zaleplon—GABRB2—Clobazam—epilepsy syndrome	0.0135	0.0313	CbGbCtD
Zaleplon—GABRG2—Clonazepam—epilepsy syndrome	0.0118	0.0273	CbGbCtD
Zaleplon—GABRG2—Clobazam—epilepsy syndrome	0.0113	0.0261	CbGbCtD
Zaleplon—GABRA2—Amobarbital—epilepsy syndrome	0.0111	0.0255	CbGbCtD
Zaleplon—GABRB2—Primidone—epilepsy syndrome	0.0105	0.0242	CbGbCtD
Zaleplon—GABRA1—Clonazepam—epilepsy syndrome	0.00982	0.0227	CbGbCtD
Zaleplon—GABRA1—Clobazam—epilepsy syndrome	0.00942	0.0217	CbGbCtD
Zaleplon—GABRB2—Propofol—epilepsy syndrome	0.00939	0.0217	CbGbCtD
Zaleplon—GABRA2—Primidone—epilepsy syndrome	0.00921	0.0212	CbGbCtD
Zaleplon—GABRB3—Propofol—epilepsy syndrome	0.00886	0.0204	CbGbCtD
Zaleplon—GABRB2—Midazolam—epilepsy syndrome	0.00885	0.0204	CbGbCtD
Zaleplon—GABRG2—Primidone—epilepsy syndrome	0.00877	0.0202	CbGbCtD
Zaleplon—GABRA1—Amobarbital—epilepsy syndrome	0.00876	0.0202	CbGbCtD
Zaleplon—GABRB2—Diazepam—epilepsy syndrome	0.00851	0.0196	CbGbCtD
Zaleplon—GABRB3—Midazolam—epilepsy syndrome	0.00835	0.0193	CbGbCtD
Zaleplon—GABRA2—Propofol—epilepsy syndrome	0.00825	0.019	CbGbCtD
Zaleplon—GABRB3—Diazepam—epilepsy syndrome	0.00803	0.0185	CbGbCtD
Zaleplon—GABRG2—Propofol—epilepsy syndrome	0.00785	0.0181	CbGbCtD
Zaleplon—GABRA2—Midazolam—epilepsy syndrome	0.00778	0.0179	CbGbCtD
Zaleplon—GABRA2—Diazepam—epilepsy syndrome	0.00748	0.0172	CbGbCtD
Zaleplon—GABRG2—Midazolam—epilepsy syndrome	0.0074	0.0171	CbGbCtD
Zaleplon—GABRA1—Primidone—epilepsy syndrome	0.00729	0.0168	CbGbCtD
Zaleplon—GABRG2—Diazepam—epilepsy syndrome	0.00712	0.0164	CbGbCtD
Zaleplon—GABRA1—Propofol—epilepsy syndrome	0.00653	0.0151	CbGbCtD
Zaleplon—GABRA1—Phenobarbital—epilepsy syndrome	0.00624	0.0144	CbGbCtD
Zaleplon—GABRA1—Midazolam—epilepsy syndrome	0.00615	0.0142	CbGbCtD
Zaleplon—GABRB2—Topiramate—epilepsy syndrome	0.00605	0.014	CbGbCtD
Zaleplon—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00593	0.0137	CbGbCtD
Zaleplon—GABRA1—Diazepam—epilepsy syndrome	0.00591	0.0136	CbGbCtD
Zaleplon—GABRG2—Topiramate—epilepsy syndrome	0.00506	0.0117	CbGbCtD
Zaleplon—CYP3A7—Carbamazepine—epilepsy syndrome	0.00496	0.0114	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00496	0.0114	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00445	0.0103	CbGbCtD
Zaleplon—CYP3A7—Phenytoin—epilepsy syndrome	0.00445	0.0103	CbGbCtD
Zaleplon—GABRA1—Topiramate—epilepsy syndrome	0.00421	0.00971	CbGbCtD
Zaleplon—CYP3A7—Phenobarbital—epilepsy syndrome	0.00397	0.00915	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00397	0.00915	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00391	0.00902	CbGbCtD
Zaleplon—CYP3A7—Midazolam—epilepsy syndrome	0.00391	0.00902	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00376	0.00867	CbGbCtD
Zaleplon—CYP3A7—Diazepam—epilepsy syndrome	0.00376	0.00867	CbGbCtD
Zaleplon—CYP3A5—Carbamazepine—epilepsy syndrome	0.00372	0.00859	CbGbCtD
Zaleplon—CYP3A5—Phenytoin—epilepsy syndrome	0.00334	0.0077	CbGbCtD
Zaleplon—CYP3A5—Phenobarbital—epilepsy syndrome	0.00297	0.00686	CbGbCtD
Zaleplon—CYP3A5—Midazolam—epilepsy syndrome	0.00293	0.00677	CbGbCtD
Zaleplon—CYP3A5—Diazepam—epilepsy syndrome	0.00282	0.00651	CbGbCtD
Zaleplon—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00231	0.00533	CbGbCtD
Zaleplon—CYP3A5—Valproic Acid—epilepsy syndrome	0.00222	0.00513	CbGbCtD
Zaleplon—CYP3A4—Trimethadione—epilepsy syndrome	0.00215	0.00496	CbGbCtD
Zaleplon—CYP3A4—Felbamate—epilepsy syndrome	0.00215	0.00496	CbGbCtD
Zaleplon—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00202	0.00466	CbGbCtD
Zaleplon—CYP3A4—Clonazepam—epilepsy syndrome	0.00183	0.00421	CbGbCtD
Zaleplon—CYP3A4—Clobazam—epilepsy syndrome	0.00175	0.00404	CbGbCtD
Zaleplon—CYP3A4—Rufinamide—epilepsy syndrome	0.00149	0.00344	CbGbCtD
Zaleplon—CYP3A4—Carbamazepine—epilepsy syndrome	0.00145	0.00335	CbGbCtD
Zaleplon—CYP3A4—Primidone—epilepsy syndrome	0.00135	0.00313	CbGbCtD
Zaleplon—CYP3A4—Phenytoin—epilepsy syndrome	0.0013	0.003	CbGbCtD
Zaleplon—CYP3A4—Propofol—epilepsy syndrome	0.00121	0.0028	CbGbCtD
Zaleplon—CYP3A4—Phenobarbital—epilepsy syndrome	0.00116	0.00268	CbGbCtD
Zaleplon—CYP3A4—Acetazolamide—epilepsy syndrome	0.00116	0.00268	CbGbCtD
Zaleplon—CYP3A4—Midazolam—epilepsy syndrome	0.00114	0.00264	CbGbCtD
Zaleplon—CYP3A4—Diazepam—epilepsy syndrome	0.0011	0.00254	CbGbCtD
Zaleplon—CYP3A4—Zonisamide—epilepsy syndrome	0.00107	0.00248	CbGbCtD
Zaleplon—GABRA2—ganglion—epilepsy syndrome	0.000921	0.0476	CbGeAlD
Zaleplon—CYP3A4—Valproic Acid—epilepsy syndrome	0.000867	0.002	CbGbCtD
Zaleplon—CYP3A4—Topiramate—epilepsy syndrome	0.000782	0.0018	CbGbCtD
Zaleplon—GABRB2—hindbrain—epilepsy syndrome	0.000764	0.0395	CbGeAlD
Zaleplon—GABRA2—hindbrain—epilepsy syndrome	0.000698	0.0361	CbGeAlD
Zaleplon—GABRA1—hindbrain—epilepsy syndrome	0.000675	0.0349	CbGeAlD
Zaleplon—GABRB2—brainstem—epilepsy syndrome	0.000438	0.0227	CbGeAlD
Zaleplon—GABRB2—forebrain—epilepsy syndrome	0.000423	0.0219	CbGeAlD
Zaleplon—GABRG2—forebrain—epilepsy syndrome	0.000423	0.0219	CbGeAlD
Zaleplon—GABRA2—brainstem—epilepsy syndrome	0.0004	0.0207	CbGeAlD
Zaleplon—GABRB2—telencephalon—epilepsy syndrome	0.000389	0.0201	CbGeAlD
Zaleplon—GABRG2—telencephalon—epilepsy syndrome	0.000389	0.0201	CbGeAlD
Zaleplon—GABRA1—brainstem—epilepsy syndrome	0.000387	0.02	CbGeAlD
Zaleplon—GABRA2—forebrain—epilepsy syndrome	0.000386	0.02	CbGeAlD
Zaleplon—GABRA1—forebrain—epilepsy syndrome	0.000373	0.0193	CbGeAlD
Zaleplon—TSPO—brainstem—epilepsy syndrome	0.000371	0.0192	CbGeAlD
Zaleplon—TSPO—forebrain—epilepsy syndrome	0.000358	0.0185	CbGeAlD
Zaleplon—GABRA2—telencephalon—epilepsy syndrome	0.000355	0.0184	CbGeAlD
Zaleplon—GABRA1—telencephalon—epilepsy syndrome	0.000343	0.0178	CbGeAlD
Zaleplon—TSPO—telencephalon—epilepsy syndrome	0.000329	0.017	CbGeAlD
Zaleplon—GABRB3—forebrain—epilepsy syndrome	0.000325	0.0168	CbGeAlD
Zaleplon—GABRB2—medulla oblongata—epilepsy syndrome	0.000305	0.0158	CbGeAlD
Zaleplon—GABRG2—medulla oblongata—epilepsy syndrome	0.000305	0.0158	CbGeAlD
Zaleplon—GABRB3—telencephalon—epilepsy syndrome	0.000299	0.0154	CbGeAlD
Zaleplon—GABRB2—midbrain—epilepsy syndrome	0.000279	0.0144	CbGeAlD
Zaleplon—GABRG2—midbrain—epilepsy syndrome	0.000279	0.0144	CbGeAlD
Zaleplon—GABRG2—spinal cord—epilepsy syndrome	0.000272	0.0141	CbGeAlD
Zaleplon—GABRB2—spinal cord—epilepsy syndrome	0.000272	0.0141	CbGeAlD
Zaleplon—GABRA1—medulla oblongata—epilepsy syndrome	0.00027	0.014	CbGeAlD
Zaleplon—TSPO—medulla oblongata—epilepsy syndrome	0.000258	0.0134	CbGeAlD
Zaleplon—GABRA1—midbrain—epilepsy syndrome	0.000247	0.0128	CbGeAlD
Zaleplon—GABRB2—head—epilepsy syndrome	0.000242	0.0125	CbGeAlD
Zaleplon—GABRG2—head—epilepsy syndrome	0.000242	0.0125	CbGeAlD
Zaleplon—GABRA1—spinal cord—epilepsy syndrome	0.000241	0.0124	CbGeAlD
Zaleplon—TSPO—midbrain—epilepsy syndrome	0.000236	0.0122	CbGeAlD
Zaleplon—GABRB3—medulla oblongata—epilepsy syndrome	0.000235	0.0121	CbGeAlD
Zaleplon—TSPO—spinal cord—epilepsy syndrome	0.00023	0.0119	CbGeAlD
Zaleplon—GABRG2—nervous system—epilepsy syndrome	0.00023	0.0119	CbGeAlD
Zaleplon—GABRB2—nervous system—epilepsy syndrome	0.00023	0.0119	CbGeAlD
Zaleplon—GABRA2—head—epilepsy syndrome	0.000221	0.0114	CbGeAlD
Zaleplon—GABRB2—central nervous system—epilepsy syndrome	0.000221	0.0114	CbGeAlD
Zaleplon—GABRG2—central nervous system—epilepsy syndrome	0.000221	0.0114	CbGeAlD
Zaleplon—GABRB2—cerebellum—epilepsy syndrome	0.000216	0.0112	CbGeAlD
Zaleplon—GABRG2—cerebellum—epilepsy syndrome	0.000216	0.0112	CbGeAlD
Zaleplon—GABRB3—midbrain—epilepsy syndrome	0.000214	0.0111	CbGeAlD
Zaleplon—AOX1—cerebellum—epilepsy syndrome	0.000214	0.0111	CbGeAlD
Zaleplon—GABRA1—head—epilepsy syndrome	0.000214	0.0111	CbGeAlD
Zaleplon—GABRA2—nervous system—epilepsy syndrome	0.00021	0.0108	CbGeAlD
Zaleplon—GABRB3—spinal cord—epilepsy syndrome	0.000209	0.0108	CbGeAlD
Zaleplon—TSPO—head—epilepsy syndrome	0.000205	0.0106	CbGeAlD
Zaleplon—GABRA1—nervous system—epilepsy syndrome	0.000203	0.0105	CbGeAlD
Zaleplon—GABRA2—central nervous system—epilepsy syndrome	0.000202	0.0104	CbGeAlD
Zaleplon—GABRA2—cerebellum—epilepsy syndrome	0.000197	0.0102	CbGeAlD
Zaleplon—GABRA1—central nervous system—epilepsy syndrome	0.000195	0.0101	CbGeAlD
Zaleplon—TSPO—nervous system—epilepsy syndrome	0.000194	0.01	CbGeAlD
Zaleplon—GABRA1—cerebellum—epilepsy syndrome	0.000191	0.00987	CbGeAlD
Zaleplon—TSPO—central nervous system—epilepsy syndrome	0.000187	0.00967	CbGeAlD
Zaleplon—GABRB3—head—epilepsy syndrome	0.000186	0.00962	CbGeAlD
Zaleplon—TSPO—cerebellum—epilepsy syndrome	0.000183	0.00945	CbGeAlD
Zaleplon—GABRB3—nervous system—epilepsy syndrome	0.000176	0.00912	CbGeAlD
Zaleplon—GABRB2—brain—epilepsy syndrome	0.000175	0.00908	CbGeAlD
Zaleplon—GABRG2—brain—epilepsy syndrome	0.000175	0.00908	CbGeAlD
Zaleplon—AOX1—brain—epilepsy syndrome	0.000174	0.00899	CbGeAlD
Zaleplon—GABRB3—central nervous system—epilepsy syndrome	0.00017	0.00878	CbGeAlD
Zaleplon—GABRB3—cerebellum—epilepsy syndrome	0.000166	0.00858	CbGeAlD
Zaleplon—GABRA2—brain—epilepsy syndrome	0.00016	0.00829	CbGeAlD
Zaleplon—GABRA1—brain—epilepsy syndrome	0.000155	0.00801	CbGeAlD
Zaleplon—TSPO—brain—epilepsy syndrome	0.000148	0.00768	CbGeAlD
Zaleplon—GABRB3—brain—epilepsy syndrome	0.000135	0.00697	CbGeAlD
Zaleplon—CYP3A4—nervous system—epilepsy syndrome	9.02e-05	0.00467	CbGeAlD
Zaleplon—CYP3A4—central nervous system—epilepsy syndrome	8.69e-05	0.00449	CbGeAlD
Zaleplon—Vertigo—Pregabalin—epilepsy syndrome	1.66e-05	0.000116	CcSEcCtD
Zaleplon—Body temperature increased—Lamotrigine—epilepsy syndrome	1.66e-05	0.000116	CcSEcCtD
Zaleplon—Abdominal pain—Lamotrigine—epilepsy syndrome	1.66e-05	0.000116	CcSEcCtD
Zaleplon—Dysgeusia—Gabapentin—epilepsy syndrome	1.66e-05	0.000116	CcSEcCtD
Zaleplon—Dizziness—Diazepam—epilepsy syndrome	1.66e-05	0.000116	CcSEcCtD
Zaleplon—Syncope—Pregabalin—epilepsy syndrome	1.66e-05	0.000115	CcSEcCtD
Zaleplon—Rash—Fosphenytoin—epilepsy syndrome	1.65e-05	0.000115	CcSEcCtD
Zaleplon—Dermatitis—Fosphenytoin—epilepsy syndrome	1.65e-05	0.000115	CcSEcCtD
Zaleplon—Nervousness—Gabapentin—epilepsy syndrome	1.65e-05	0.000115	CcSEcCtD
Zaleplon—Asthenia—Clonazepam—epilepsy syndrome	1.65e-05	0.000115	CcSEcCtD
Zaleplon—Back pain—Gabapentin—epilepsy syndrome	1.64e-05	0.000114	CcSEcCtD
Zaleplon—Headache—Fosphenytoin—epilepsy syndrome	1.64e-05	0.000114	CcSEcCtD
Zaleplon—Nervous system disorder—Valproic Acid—epilepsy syndrome	1.64e-05	0.000114	CcSEcCtD
Zaleplon—Palpitations—Pregabalin—epilepsy syndrome	1.64e-05	0.000114	CcSEcCtD
Zaleplon—Asthenia—Phenytoin—epilepsy syndrome	1.64e-05	0.000114	CcSEcCtD
Zaleplon—Nausea—Midazolam—epilepsy syndrome	1.63e-05	0.000114	CcSEcCtD
Zaleplon—Hypoaesthesia—Topiramate—epilepsy syndrome	1.63e-05	0.000114	CcSEcCtD
Zaleplon—Hallucination—Topiramate—epilepsy syndrome	1.63e-05	0.000114	CcSEcCtD
Zaleplon—Tachycardia—Valproic Acid—epilepsy syndrome	1.63e-05	0.000113	CcSEcCtD
Zaleplon—Loss of consciousness—Pregabalin—epilepsy syndrome	1.63e-05	0.000113	CcSEcCtD
Zaleplon—Asthenia—Oxcarbazepine—epilepsy syndrome	1.63e-05	0.000113	CcSEcCtD
Zaleplon—Pruritus—Clonazepam—epilepsy syndrome	1.62e-05	0.000113	CcSEcCtD
Zaleplon—Skin disorder—Valproic Acid—epilepsy syndrome	1.62e-05	0.000113	CcSEcCtD
Zaleplon—Oedema peripheral—Topiramate—epilepsy syndrome	1.62e-05	0.000112	CcSEcCtD
Zaleplon—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.62e-05	0.000112	CcSEcCtD
Zaleplon—Pruritus—Phenytoin—epilepsy syndrome	1.61e-05	0.000112	CcSEcCtD
Zaleplon—Nausea—Levetiracetam—epilepsy syndrome	1.61e-05	0.000112	CcSEcCtD
Zaleplon—Rash—Vigabatrin—epilepsy syndrome	1.61e-05	0.000112	CcSEcCtD
Zaleplon—Dizziness—Felbamate—epilepsy syndrome	1.61e-05	0.000112	CcSEcCtD
Zaleplon—Dermatitis—Vigabatrin—epilepsy syndrome	1.61e-05	0.000112	CcSEcCtD
Zaleplon—Pruritus—Oxcarbazepine—epilepsy syndrome	1.6e-05	0.000112	CcSEcCtD
Zaleplon—Headache—Vigabatrin—epilepsy syndrome	1.6e-05	0.000111	CcSEcCtD
Zaleplon—Hypertension—Pregabalin—epilepsy syndrome	1.6e-05	0.000111	CcSEcCtD
Zaleplon—Anorexia—Valproic Acid—epilepsy syndrome	1.59e-05	0.000111	CcSEcCtD
Zaleplon—Tremor—Gabapentin—epilepsy syndrome	1.59e-05	0.000111	CcSEcCtD
Zaleplon—Rash—Diazepam—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Dermatitis—Diazepam—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Visual impairment—Topiramate—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Chest pain—Pregabalin—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Arthralgia—Pregabalin—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Myalgia—Pregabalin—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.58e-05	0.00011	CcSEcCtD
Zaleplon—Dizziness—Zonisamide—epilepsy syndrome	1.57e-05	0.00011	CcSEcCtD
Zaleplon—Headache—Diazepam—epilepsy syndrome	1.57e-05	0.00011	CcSEcCtD
Zaleplon—Anxiety—Pregabalin—epilepsy syndrome	1.57e-05	0.000109	CcSEcCtD
Zaleplon—Anaemia—Gabapentin—epilepsy syndrome	1.57e-05	0.000109	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.57e-05	0.000109	CcSEcCtD
Zaleplon—Hypotension—Valproic Acid—epilepsy syndrome	1.56e-05	0.000109	CcSEcCtD
Zaleplon—Asthenia—Carbamazepine—epilepsy syndrome	1.56e-05	0.000109	CcSEcCtD
Zaleplon—Agitation—Gabapentin—epilepsy syndrome	1.56e-05	0.000109	CcSEcCtD
Zaleplon—Discomfort—Pregabalin—epilepsy syndrome	1.56e-05	0.000108	CcSEcCtD
Zaleplon—Nausea—Fosphenytoin—epilepsy syndrome	1.56e-05	0.000108	CcSEcCtD
Zaleplon—Angioedema—Gabapentin—epilepsy syndrome	1.55e-05	0.000108	CcSEcCtD
Zaleplon—Dry mouth—Pregabalin—epilepsy syndrome	1.54e-05	0.000107	CcSEcCtD
Zaleplon—Pruritus—Carbamazepine—epilepsy syndrome	1.54e-05	0.000107	CcSEcCtD
Zaleplon—Rash—Felbamate—epilepsy syndrome	1.53e-05	0.000107	CcSEcCtD
Zaleplon—Eye disorder—Topiramate—epilepsy syndrome	1.53e-05	0.000107	CcSEcCtD
Zaleplon—Dermatitis—Felbamate—epilepsy syndrome	1.53e-05	0.000107	CcSEcCtD
Zaleplon—Malaise—Gabapentin—epilepsy syndrome	1.53e-05	0.000106	CcSEcCtD
Zaleplon—Tinnitus—Topiramate—epilepsy syndrome	1.53e-05	0.000106	CcSEcCtD
Zaleplon—Vertigo—Gabapentin—epilepsy syndrome	1.53e-05	0.000106	CcSEcCtD
Zaleplon—Headache—Felbamate—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Confusional state—Pregabalin—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Syncope—Gabapentin—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Dizziness—Clonazepam—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Nausea—Vigabatrin—epilepsy syndrome	1.52e-05	0.000106	CcSEcCtD
Zaleplon—Insomnia—Valproic Acid—epilepsy syndrome	1.51e-05	0.000105	CcSEcCtD
Zaleplon—Oedema—Pregabalin—epilepsy syndrome	1.51e-05	0.000105	CcSEcCtD
Zaleplon—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.51e-05	0.000105	CcSEcCtD
Zaleplon—Asthenia—Lamotrigine—epilepsy syndrome	1.51e-05	0.000105	CcSEcCtD
Zaleplon—Dizziness—Phenytoin—epilepsy syndrome	1.51e-05	0.000105	CcSEcCtD
Zaleplon—Rash—Zonisamide—epilepsy syndrome	1.5e-05	0.000104	CcSEcCtD
Zaleplon—Paraesthesia—Valproic Acid—epilepsy syndrome	1.5e-05	0.000104	CcSEcCtD
Zaleplon—Palpitations—Gabapentin—epilepsy syndrome	1.5e-05	0.000104	CcSEcCtD
Zaleplon—Dermatitis—Zonisamide—epilepsy syndrome	1.5e-05	0.000104	CcSEcCtD
Zaleplon—Dizziness—Oxcarbazepine—epilepsy syndrome	1.5e-05	0.000104	CcSEcCtD
Zaleplon—Nausea—Diazepam—epilepsy syndrome	1.49e-05	0.000104	CcSEcCtD
Zaleplon—Loss of consciousness—Gabapentin—epilepsy syndrome	1.49e-05	0.000104	CcSEcCtD
Zaleplon—Headache—Zonisamide—epilepsy syndrome	1.49e-05	0.000104	CcSEcCtD
Zaleplon—Dyspnoea—Valproic Acid—epilepsy syndrome	1.49e-05	0.000104	CcSEcCtD
Zaleplon—Pruritus—Lamotrigine—epilepsy syndrome	1.49e-05	0.000104	CcSEcCtD
Zaleplon—Shock—Pregabalin—epilepsy syndrome	1.49e-05	0.000103	CcSEcCtD
Zaleplon—Somnolence—Valproic Acid—epilepsy syndrome	1.49e-05	0.000103	CcSEcCtD
Zaleplon—Immune system disorder—Topiramate—epilepsy syndrome	1.48e-05	0.000103	CcSEcCtD
Zaleplon—Nervous system disorder—Pregabalin—epilepsy syndrome	1.48e-05	0.000103	CcSEcCtD
Zaleplon—Tachycardia—Pregabalin—epilepsy syndrome	1.47e-05	0.000103	CcSEcCtD
Zaleplon—Chills—Topiramate—epilepsy syndrome	1.47e-05	0.000102	CcSEcCtD
Zaleplon—Dyspepsia—Valproic Acid—epilepsy syndrome	1.47e-05	0.000102	CcSEcCtD
Zaleplon—Skin disorder—Pregabalin—epilepsy syndrome	1.47e-05	0.000102	CcSEcCtD
Zaleplon—Hypertension—Gabapentin—epilepsy syndrome	1.47e-05	0.000102	CcSEcCtD
Zaleplon—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.46e-05	0.000102	CcSEcCtD
Zaleplon—Decreased appetite—Valproic Acid—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Alopecia—Topiramate—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Rash—Clonazepam—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Dermatitis—Clonazepam—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Arthralgia—Gabapentin—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Chest pain—Gabapentin—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Myalgia—Gabapentin—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Nausea—Felbamate—epilepsy syndrome	1.45e-05	0.000101	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Anxiety—Gabapentin—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Anorexia—Pregabalin—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Dizziness—Carbamazepine—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Headache—Clonazepam—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Rash—Phenytoin—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Mental disorder—Topiramate—epilepsy syndrome	1.44e-05	0.0001	CcSEcCtD
Zaleplon—Dermatitis—Phenytoin—epilepsy syndrome	1.44e-05	9.99e-05	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.44e-05	9.99e-05	CcSEcCtD
Zaleplon—Rash—Oxcarbazepine—epilepsy syndrome	1.43e-05	9.95e-05	CcSEcCtD
Zaleplon—Pain—Valproic Acid—epilepsy syndrome	1.43e-05	9.94e-05	CcSEcCtD
Zaleplon—Constipation—Valproic Acid—epilepsy syndrome	1.43e-05	9.94e-05	CcSEcCtD
Zaleplon—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.43e-05	9.94e-05	CcSEcCtD
Zaleplon—Headache—Phenytoin—epilepsy syndrome	1.43e-05	9.94e-05	CcSEcCtD
Zaleplon—Malnutrition—Topiramate—epilepsy syndrome	1.43e-05	9.94e-05	CcSEcCtD
Zaleplon—Discomfort—Gabapentin—epilepsy syndrome	1.43e-05	9.93e-05	CcSEcCtD
Zaleplon—Headache—Oxcarbazepine—epilepsy syndrome	1.42e-05	9.88e-05	CcSEcCtD
Zaleplon—Nausea—Zonisamide—epilepsy syndrome	1.41e-05	9.84e-05	CcSEcCtD
Zaleplon—Dry mouth—Gabapentin—epilepsy syndrome	1.41e-05	9.83e-05	CcSEcCtD
Zaleplon—Hypotension—Pregabalin—epilepsy syndrome	1.41e-05	9.82e-05	CcSEcCtD
Zaleplon—Flatulence—Topiramate—epilepsy syndrome	1.41e-05	9.79e-05	CcSEcCtD
Zaleplon—Tension—Topiramate—epilepsy syndrome	1.4e-05	9.75e-05	CcSEcCtD
Zaleplon—Dysgeusia—Topiramate—epilepsy syndrome	1.4e-05	9.73e-05	CcSEcCtD
Zaleplon—Confusional state—Gabapentin—epilepsy syndrome	1.4e-05	9.72e-05	CcSEcCtD
Zaleplon—Dizziness—Lamotrigine—epilepsy syndrome	1.39e-05	9.68e-05	CcSEcCtD
Zaleplon—Nervousness—Topiramate—epilepsy syndrome	1.39e-05	9.65e-05	CcSEcCtD
Zaleplon—Oedema—Gabapentin—epilepsy syndrome	1.39e-05	9.64e-05	CcSEcCtD
Zaleplon—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.39e-05	9.64e-05	CcSEcCtD
Zaleplon—Back pain—Topiramate—epilepsy syndrome	1.38e-05	9.61e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.38e-05	9.58e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.38e-05	9.58e-05	CcSEcCtD
Zaleplon—Rash—Carbamazepine—epilepsy syndrome	1.37e-05	9.55e-05	CcSEcCtD
Zaleplon—Dermatitis—Carbamazepine—epilepsy syndrome	1.37e-05	9.54e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.37e-05	9.51e-05	CcSEcCtD
Zaleplon—Insomnia—Pregabalin—epilepsy syndrome	1.37e-05	9.51e-05	CcSEcCtD
Zaleplon—Nausea—Clonazepam—epilepsy syndrome	1.36e-05	9.48e-05	CcSEcCtD
Zaleplon—Headache—Carbamazepine—epilepsy syndrome	1.36e-05	9.48e-05	CcSEcCtD
Zaleplon—Shock—Gabapentin—epilepsy syndrome	1.36e-05	9.48e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Gabapentin—epilepsy syndrome	1.36e-05	9.45e-05	CcSEcCtD
Zaleplon—Paraesthesia—Pregabalin—epilepsy syndrome	1.36e-05	9.44e-05	CcSEcCtD
Zaleplon—Nausea—Phenytoin—epilepsy syndrome	1.35e-05	9.42e-05	CcSEcCtD
Zaleplon—Tachycardia—Gabapentin—epilepsy syndrome	1.35e-05	9.41e-05	CcSEcCtD
Zaleplon—Dyspnoea—Pregabalin—epilepsy syndrome	1.35e-05	9.37e-05	CcSEcCtD
Zaleplon—Nausea—Oxcarbazepine—epilepsy syndrome	1.35e-05	9.37e-05	CcSEcCtD
Zaleplon—Skin disorder—Gabapentin—epilepsy syndrome	1.35e-05	9.36e-05	CcSEcCtD
Zaleplon—Somnolence—Pregabalin—epilepsy syndrome	1.34e-05	9.34e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.34e-05	9.32e-05	CcSEcCtD
Zaleplon—Tremor—Topiramate—epilepsy syndrome	1.34e-05	9.31e-05	CcSEcCtD
Zaleplon—Urticaria—Valproic Acid—epilepsy syndrome	1.33e-05	9.24e-05	CcSEcCtD
Zaleplon—Rash—Lamotrigine—epilepsy syndrome	1.33e-05	9.23e-05	CcSEcCtD
Zaleplon—Ill-defined disorder—Topiramate—epilepsy syndrome	1.33e-05	9.22e-05	CcSEcCtD
Zaleplon—Dermatitis—Lamotrigine—epilepsy syndrome	1.32e-05	9.22e-05	CcSEcCtD
Zaleplon—Abdominal pain—Valproic Acid—epilepsy syndrome	1.32e-05	9.19e-05	CcSEcCtD
Zaleplon—Body temperature increased—Valproic Acid—epilepsy syndrome	1.32e-05	9.19e-05	CcSEcCtD
Zaleplon—Anorexia—Gabapentin—epilepsy syndrome	1.32e-05	9.19e-05	CcSEcCtD
Zaleplon—Anaemia—Topiramate—epilepsy syndrome	1.32e-05	9.18e-05	CcSEcCtD
Zaleplon—Headache—Lamotrigine—epilepsy syndrome	1.32e-05	9.17e-05	CcSEcCtD
Zaleplon—Decreased appetite—Pregabalin—epilepsy syndrome	1.31e-05	9.14e-05	CcSEcCtD
Zaleplon—Agitation—Topiramate—epilepsy syndrome	1.31e-05	9.13e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.3e-05	9.07e-05	CcSEcCtD
Zaleplon—Hypotension—Gabapentin—epilepsy syndrome	1.29e-05	9.01e-05	CcSEcCtD
Zaleplon—Nausea—Carbamazepine—epilepsy syndrome	1.29e-05	8.99e-05	CcSEcCtD
Zaleplon—Constipation—Pregabalin—epilepsy syndrome	1.29e-05	8.99e-05	CcSEcCtD
Zaleplon—Pain—Pregabalin—epilepsy syndrome	1.29e-05	8.99e-05	CcSEcCtD
Zaleplon—Malaise—Topiramate—epilepsy syndrome	1.29e-05	8.96e-05	CcSEcCtD
Zaleplon—Vertigo—Topiramate—epilepsy syndrome	1.28e-05	8.93e-05	CcSEcCtD
Zaleplon—Syncope—Topiramate—epilepsy syndrome	1.28e-05	8.91e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.26e-05	8.78e-05	CcSEcCtD
Zaleplon—Palpitations—Topiramate—epilepsy syndrome	1.26e-05	8.78e-05	CcSEcCtD
Zaleplon—Loss of consciousness—Topiramate—epilepsy syndrome	1.26e-05	8.73e-05	CcSEcCtD
Zaleplon—Insomnia—Gabapentin—epilepsy syndrome	1.25e-05	8.72e-05	CcSEcCtD
Zaleplon—Nausea—Lamotrigine—epilepsy syndrome	1.25e-05	8.69e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Pregabalin—epilepsy syndrome	1.25e-05	8.66e-05	CcSEcCtD
Zaleplon—Paraesthesia—Gabapentin—epilepsy syndrome	1.24e-05	8.65e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.24e-05	8.6e-05	CcSEcCtD
Zaleplon—Dyspnoea—Gabapentin—epilepsy syndrome	1.24e-05	8.59e-05	CcSEcCtD
Zaleplon—Hypertension—Topiramate—epilepsy syndrome	1.23e-05	8.58e-05	CcSEcCtD
Zaleplon—Somnolence—Gabapentin—epilepsy syndrome	1.23e-05	8.57e-05	CcSEcCtD
Zaleplon—Dyspepsia—Gabapentin—epilepsy syndrome	1.22e-05	8.48e-05	CcSEcCtD
Zaleplon—Myalgia—Topiramate—epilepsy syndrome	1.22e-05	8.46e-05	CcSEcCtD
Zaleplon—Chest pain—Topiramate—epilepsy syndrome	1.22e-05	8.46e-05	CcSEcCtD
Zaleplon—Arthralgia—Topiramate—epilepsy syndrome	1.22e-05	8.46e-05	CcSEcCtD
Zaleplon—Anxiety—Topiramate—epilepsy syndrome	1.21e-05	8.43e-05	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.21e-05	8.4e-05	CcSEcCtD
Zaleplon—Decreased appetite—Gabapentin—epilepsy syndrome	1.2e-05	8.38e-05	CcSEcCtD
Zaleplon—Discomfort—Topiramate—epilepsy syndrome	1.2e-05	8.36e-05	CcSEcCtD
Zaleplon—Urticaria—Pregabalin—epilepsy syndrome	1.2e-05	8.35e-05	CcSEcCtD
Zaleplon—Asthenia—Valproic Acid—epilepsy syndrome	1.2e-05	8.34e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.2e-05	8.32e-05	CcSEcCtD
Zaleplon—Body temperature increased—Pregabalin—epilepsy syndrome	1.19e-05	8.31e-05	CcSEcCtD
Zaleplon—Abdominal pain—Pregabalin—epilepsy syndrome	1.19e-05	8.31e-05	CcSEcCtD
Zaleplon—Dry mouth—Topiramate—epilepsy syndrome	1.19e-05	8.27e-05	CcSEcCtD
Zaleplon—Pain—Gabapentin—epilepsy syndrome	1.18e-05	8.24e-05	CcSEcCtD
Zaleplon—Constipation—Gabapentin—epilepsy syndrome	1.18e-05	8.24e-05	CcSEcCtD
Zaleplon—Pruritus—Valproic Acid—epilepsy syndrome	1.18e-05	8.23e-05	CcSEcCtD
Zaleplon—Confusional state—Topiramate—epilepsy syndrome	1.18e-05	8.18e-05	CcSEcCtD
Zaleplon—Oedema—Topiramate—epilepsy syndrome	1.17e-05	8.11e-05	CcSEcCtD
Zaleplon—Shock—Topiramate—epilepsy syndrome	1.15e-05	7.98e-05	CcSEcCtD
Zaleplon—Nervous system disorder—Topiramate—epilepsy syndrome	1.14e-05	7.95e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Gabapentin—epilepsy syndrome	1.14e-05	7.94e-05	CcSEcCtD
Zaleplon—Tachycardia—Topiramate—epilepsy syndrome	1.14e-05	7.91e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.13e-05	7.88e-05	CcSEcCtD
Zaleplon—Skin disorder—Topiramate—epilepsy syndrome	1.13e-05	7.88e-05	CcSEcCtD
Zaleplon—Hyperhidrosis—Topiramate—epilepsy syndrome	1.13e-05	7.84e-05	CcSEcCtD
Zaleplon—Anorexia—Topiramate—epilepsy syndrome	1.11e-05	7.73e-05	CcSEcCtD
Zaleplon—Dizziness—Valproic Acid—epilepsy syndrome	1.11e-05	7.69e-05	CcSEcCtD
Zaleplon—Urticaria—Gabapentin—epilepsy syndrome	1.1e-05	7.66e-05	CcSEcCtD
Zaleplon—Body temperature increased—Gabapentin—epilepsy syndrome	1.1e-05	7.62e-05	CcSEcCtD
Zaleplon—Abdominal pain—Gabapentin—epilepsy syndrome	1.1e-05	7.62e-05	CcSEcCtD
Zaleplon—Hypotension—Topiramate—epilepsy syndrome	1.09e-05	7.58e-05	CcSEcCtD
Zaleplon—Asthenia—Pregabalin—epilepsy syndrome	1.08e-05	7.54e-05	CcSEcCtD
Zaleplon—Pruritus—Pregabalin—epilepsy syndrome	1.07e-05	7.44e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.06e-05	7.39e-05	CcSEcCtD
Zaleplon—Insomnia—Topiramate—epilepsy syndrome	1.05e-05	7.33e-05	CcSEcCtD
Zaleplon—Rash—Valproic Acid—epilepsy syndrome	1.05e-05	7.33e-05	CcSEcCtD
Zaleplon—Dermatitis—Valproic Acid—epilepsy syndrome	1.05e-05	7.32e-05	CcSEcCtD
Zaleplon—Headache—Valproic Acid—epilepsy syndrome	1.05e-05	7.28e-05	CcSEcCtD
Zaleplon—Paraesthesia—Topiramate—epilepsy syndrome	1.05e-05	7.28e-05	CcSEcCtD
Zaleplon—Dyspnoea—Topiramate—epilepsy syndrome	1.04e-05	7.23e-05	CcSEcCtD
Zaleplon—Somnolence—Topiramate—epilepsy syndrome	1.04e-05	7.21e-05	CcSEcCtD
Zaleplon—Dyspepsia—Topiramate—epilepsy syndrome	1.03e-05	7.14e-05	CcSEcCtD
Zaleplon—Decreased appetite—Topiramate—epilepsy syndrome	1.01e-05	7.05e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.01e-05	7e-05	CcSEcCtD
Zaleplon—Dizziness—Pregabalin—epilepsy syndrome	9.99e-06	6.95e-05	CcSEcCtD
Zaleplon—Pain—Topiramate—epilepsy syndrome	9.97e-06	6.93e-05	CcSEcCtD
Zaleplon—Constipation—Topiramate—epilepsy syndrome	9.97e-06	6.93e-05	CcSEcCtD
Zaleplon—Asthenia—Gabapentin—epilepsy syndrome	9.94e-06	6.92e-05	CcSEcCtD
Zaleplon—Nausea—Valproic Acid—epilepsy syndrome	9.93e-06	6.91e-05	CcSEcCtD
Zaleplon—Pruritus—Gabapentin—epilepsy syndrome	9.8e-06	6.82e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Topiramate—epilepsy syndrome	9.61e-06	6.68e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.53e-06	6.63e-05	CcSEcCtD
Zaleplon—Rash—Pregabalin—epilepsy syndrome	9.53e-06	6.63e-05	CcSEcCtD
Zaleplon—Dermatitis—Pregabalin—epilepsy syndrome	9.52e-06	6.62e-05	CcSEcCtD
Zaleplon—Headache—Pregabalin—epilepsy syndrome	9.47e-06	6.58e-05	CcSEcCtD
Zaleplon—Urticaria—Topiramate—epilepsy syndrome	9.26e-06	6.44e-05	CcSEcCtD
Zaleplon—Body temperature increased—Topiramate—epilepsy syndrome	9.21e-06	6.41e-05	CcSEcCtD
Zaleplon—Abdominal pain—Topiramate—epilepsy syndrome	9.21e-06	6.41e-05	CcSEcCtD
Zaleplon—Dizziness—Gabapentin—epilepsy syndrome	9.16e-06	6.37e-05	CcSEcCtD
Zaleplon—CYP3A7—Metabolism—COX3—epilepsy syndrome	9.14e-06	0.000135	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—SRC—epilepsy syndrome	9.13e-06	0.000135	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—PRKCB—epilepsy syndrome	8.99e-06	0.000133	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.99e-06	0.000133	CbGpPWpGaD
Zaleplon—Nausea—Pregabalin—epilepsy syndrome	8.97e-06	6.24e-05	CcSEcCtD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.89e-06	0.000131	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.76e-06	0.00013	CbGpPWpGaD
Zaleplon—Rash—Gabapentin—epilepsy syndrome	8.74e-06	6.08e-05	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.73e-06	0.000129	CbGpPWpGaD
Zaleplon—Dermatitis—Gabapentin—epilepsy syndrome	8.73e-06	6.07e-05	CcSEcCtD
Zaleplon—Headache—Gabapentin—epilepsy syndrome	8.68e-06	6.04e-05	CcSEcCtD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.68e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—KCNB1—epilepsy syndrome	8.67e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLCO1A2—epilepsy syndrome	8.67e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PFKL—epilepsy syndrome	8.67e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CACNA2D2—epilepsy syndrome	8.67e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC6A8—epilepsy syndrome	8.67e-06	0.000128	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCG2—epilepsy syndrome	8.62e-06	0.000128	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.52e-06	0.000126	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	8.46e-06	0.000125	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	8.44e-06	0.000125	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2C19—epilepsy syndrome	8.4e-06	0.000124	CbGpPWpGaD
Zaleplon—Asthenia—Topiramate—epilepsy syndrome	8.36e-06	5.82e-05	CcSEcCtD
Zaleplon—AOX1—Metabolism—CYP11A1—epilepsy syndrome	8.35e-06	0.000124	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.33e-06	0.000123	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.28e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADK—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FAR1—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CERS1—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PDXK—epilepsy syndrome	8.27e-06	0.000122	CbGpPWpGaD
Zaleplon—Pruritus—Topiramate—epilepsy syndrome	8.25e-06	5.74e-05	CcSEcCtD
Zaleplon—Nausea—Gabapentin—epilepsy syndrome	8.23e-06	5.73e-05	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	8.2e-06	0.000121	CbGpPWpGaD
Zaleplon—AOX1—Disease—SLC2A1—epilepsy syndrome	8.14e-06	0.00012	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.13e-06	0.00012	CbGpPWpGaD
Zaleplon—AOX1—Disease—JUNB—epilepsy syndrome	8.08e-06	0.000119	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS1—epilepsy syndrome	8.02e-06	0.000119	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—UPB1—epilepsy syndrome	7.93e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ATIC—epilepsy syndrome	7.93e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NEU1—epilepsy syndrome	7.93e-06	0.000117	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—PRKCB—epilepsy syndrome	7.86e-06	0.000116	CbGpPWpGaD
Zaleplon—Dizziness—Topiramate—epilepsy syndrome	7.71e-06	5.36e-05	CcSEcCtD
Zaleplon—AOX1—Disease—HBEGF—epilepsy syndrome	7.65e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSD17B4—epilepsy syndrome	7.63e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.56e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	7.56e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PNPO—epilepsy syndrome	7.56e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	7.56e-06	0.000112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GAMT—epilepsy syndrome	7.56e-06	0.000112	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2D6—epilepsy syndrome	7.53e-06	0.000111	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT3—epilepsy syndrome	7.51e-06	0.000111	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.45e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	7.41e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GBE1—epilepsy syndrome	7.37e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPP1R3C—epilepsy syndrome	7.37e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	7.37e-06	0.000109	CbGpPWpGaD
Zaleplon—Rash—Topiramate—epilepsy syndrome	7.35e-06	5.11e-05	CcSEcCtD
Zaleplon—Dermatitis—Topiramate—epilepsy syndrome	7.34e-06	5.11e-05	CcSEcCtD
Zaleplon—AOX1—Disease—ADAM10—epilepsy syndrome	7.33e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	7.31e-06	0.000108	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.31e-06	0.000108	CbGpPWpGaD
Zaleplon—Headache—Topiramate—epilepsy syndrome	7.3e-06	5.08e-05	CcSEcCtD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	7.27e-06	0.000108	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.24e-06	0.000107	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ADRA2A—epilepsy syndrome	7.17e-06	0.000106	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	7.16e-06	0.000106	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—BCHE—epilepsy syndrome	7.14e-06	0.000106	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.1e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—QDPR—epilepsy syndrome	7.03e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA4—epilepsy syndrome	7.03e-06	0.000104	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.02e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	7.01e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ASAH1—epilepsy syndrome	6.93e-06	0.000103	CbGpPWpGaD
Zaleplon—Nausea—Topiramate—epilepsy syndrome	6.92e-06	4.82e-05	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.85e-06	0.000101	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDC42—epilepsy syndrome	6.85e-06	0.000101	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SLC2A1—epilepsy syndrome	6.81e-06	0.000101	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.81e-06	0.000101	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.79e-06	0.0001	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.75e-06	9.98e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—STXBP1—epilepsy syndrome	6.74e-06	9.97e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLCB1—epilepsy syndrome	6.74e-06	9.97e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TH—epilepsy syndrome	6.72e-06	9.94e-05	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.69e-06	9.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	6.65e-06	9.84e-05	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.63e-06	9.8e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—COX3—epilepsy syndrome	6.61e-06	9.78e-05	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.58e-06	9.73e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NT5E—epilepsy syndrome	6.57e-06	9.72e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALAD—epilepsy syndrome	6.57e-06	9.72e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.56e-06	9.7e-05	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.54e-06	9.67e-05	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.42e-06	9.49e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—HES1—epilepsy syndrome	6.27e-06	9.28e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CACNA1A—epilepsy syndrome	6.27e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH7A1—epilepsy syndrome	6.27e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PFKL—epilepsy syndrome	6.26e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	6.26e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	6.26e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	6.26e-06	9.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	6.26e-06	9.27e-05	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	6.14e-06	9.08e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	6.13e-06	9.07e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ST3GAL3—epilepsy syndrome	6.13e-06	9.07e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—FYN—epilepsy syndrome	6.1e-06	9.02e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—H2AFX—epilepsy syndrome	6.08e-06	8.99e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADSL—epilepsy syndrome	6.01e-06	8.89e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GLUL—epilepsy syndrome	5.89e-06	8.72e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—YWHAZ—epilepsy syndrome	5.86e-06	8.67e-05	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.84e-06	8.65e-05	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.79e-06	8.57e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CACNA1D—epilepsy syndrome	5.78e-06	8.56e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NEU1—epilepsy syndrome	5.73e-06	8.48e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UPB1—epilepsy syndrome	5.73e-06	8.48e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ATIC—epilepsy syndrome	5.73e-06	8.48e-05	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—epilepsy syndrome	5.68e-06	8.4e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—CCR5—epilepsy syndrome	5.64e-06	8.34e-05	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.61e-06	8.3e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—epilepsy syndrome	5.6e-06	8.29e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAT—epilepsy syndrome	5.53e-06	8.18e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	5.52e-06	8.16e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TXNRD1—epilepsy syndrome	5.41e-06	8e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCB1—epilepsy syndrome	5.38e-06	7.96e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GBE1—epilepsy syndrome	5.33e-06	7.88e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	5.33e-06	7.88e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AQP1—epilepsy syndrome	5.25e-06	7.77e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—TSC2—epilepsy syndrome	5.24e-06	7.76e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOE—epilepsy syndrome	5.13e-06	7.59e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA13—epilepsy syndrome	5.07e-06	7.5e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	5.01e-06	7.41e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GPX1—epilepsy syndrome	5e-06	7.4e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	4.87e-06	7.21e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6ST—epilepsy syndrome	4.82e-06	7.13e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—epilepsy syndrome	4.78e-06	7.07e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	4.75e-06	7.03e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	4.75e-06	7.03e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NT5E—epilepsy syndrome	4.75e-06	7.02e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALAD—epilepsy syndrome	4.75e-06	7.02e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	4.53e-06	6.7e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	4.53e-06	6.7e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	4.43e-06	6.56e-05	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.39e-06	6.49e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AGT—epilepsy syndrome	4.39e-06	6.49e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADSL—epilepsy syndrome	4.34e-06	6.42e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOE—epilepsy syndrome	4.3e-06	6.36e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GLUL—epilepsy syndrome	4.26e-06	6.3e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	4.18e-06	6.18e-05	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.12e-06	6.09e-05	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.09e-06	6.05e-05	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.01e-06	5.94e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	3.91e-06	5.78e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF2—epilepsy syndrome	3.9e-06	5.77e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	3.87e-06	5.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.84e-06	5.69e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AQP1—epilepsy syndrome	3.8e-06	5.62e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	3.77e-06	5.58e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	3.75e-06	5.55e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—POMC—epilepsy syndrome	3.69e-06	5.46e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTOR—epilepsy syndrome	3.55e-06	5.25e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—epilepsy syndrome	3.52e-06	5.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.51e-06	5.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.51e-06	5.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.51e-06	5.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.51e-06	5.2e-05	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.51e-06	5.19e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	3.43e-06	5.08e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	3.43e-06	5.08e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	3.38e-06	5.01e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—epilepsy syndrome	3.37e-06	4.98e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.27e-06	4.83e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.27e-06	4.83e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.26e-06	4.82e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	3.22e-06	4.77e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BCHE—epilepsy syndrome	3.21e-06	4.75e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.07e-06	4.55e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	3.06e-06	4.53e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	3.03e-06	4.48e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TH—epilepsy syndrome	3.02e-06	4.46e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	4.36e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.91e-06	4.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.91e-06	4.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.91e-06	4.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.91e-06	4.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.91e-06	4.31e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—epilepsy syndrome	2.84e-06	4.21e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.8e-06	4.14e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.73e-06	4.03e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.71e-06	4.01e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.66e-06	3.94e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.66e-06	3.94e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.66e-06	3.94e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.56e-06	3.79e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.52e-06	3.72e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.48e-06	3.67e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.48e-06	3.66e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.48e-06	3.66e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.45e-06	3.62e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.42e-06	3.57e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.33e-06	3.44e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.33e-06	3.44e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.32e-06	3.43e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.26e-06	3.35e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.25e-06	3.32e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.21e-06	3.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.21e-06	3.27e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.21e-06	3.27e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.19e-06	3.24e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TH—epilepsy syndrome	2.18e-06	3.23e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.11e-06	3.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.11e-06	3.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.06e-06	3.05e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.02e-06	2.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.98e-06	2.93e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.97e-06	2.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.94e-06	2.88e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.93e-06	2.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.82e-06	2.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.82e-06	2.69e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.8e-06	2.66e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—epilepsy syndrome	1.77e-06	2.61e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.76e-06	2.61e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.75e-06	2.58e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.66e-06	2.45e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.62e-06	2.4e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.6e-06	2.36e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.6e-06	2.36e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.51e-06	2.24e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—epilepsy syndrome	1.48e-06	2.19e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.42e-06	2.11e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.39e-06	2.06e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	1.96e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.3e-06	1.92e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.27e-06	1.88e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.26e-06	1.86e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.2e-06	1.77e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.14e-06	1.68e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.62e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.08e-06	1.6e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.08e-06	1.59e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.03e-06	1.52e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.02e-06	1.5e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TH—epilepsy syndrome	1.01e-06	1.5e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	9.56e-07	1.41e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.46e-07	1.25e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.35e-07	1.23e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.12e-07	1.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.55e-07	1.12e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—epilepsy syndrome	6.65e-07	9.83e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.62e-07	9.79e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.48e-07	9.59e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.57e-07	8.24e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.08e-07	7.51e-06	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.8e-07	7.11e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.44e-07	6.57e-06	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.23e-07	3.3e-06	CbGpPWpGaD
